Detail
LncRNA Name | BCAR4 |
Synonyms | NA |
Region | GRCh38_16:11819829-11828845 Sequence |
Ensembl | ENSG00000262117 |
RefSeq | NR_024049 |
Circulating | ✘ |
Drug-resisitant | ✔ |
Prognostic | ✔ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR etc. |
Sample | cell line (ZR-75-1) |
Expression Pattern | up-regulated |
Function Description | Forced expression of BCAR4 in human ZR-75-1 and MCF7 breast cancer cells resulted in cell proliferation in the absence of estrogen and in the presence of various antiestrogens. Inhibition of estrogen receptor 1 (ESR1) expression with small interfering RNA (siRNA), implied that the BCAR4-induced mechanism of resistance is independent of ESR1. BCAR4 is a strong transforming gene causing estrogen-independent growth and antiestrogen resistance, and induces tumor formation in vivo. Due to its restricted expression, BCAR4 may be a good target for treating antiestrogen-resistant breast cancer. |
Pubmed ID | 21506106 |
Year | 2011 |
Title | Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells. |
External Links |
Links for BCAR4 | GenBank HGNC lncrnadb Noncode |
Links for breast cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.